Related references
Note: Only part of the references are listed.Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus
Ian M. Gould
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Evaluation of a new etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA
Anne Yusof et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA)
Peter C. Appelbaum
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy
G Sakoulas et al.
CLINICAL INFECTIOUS DISEASES (2006)
A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital
M Wootton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Share Paper
